Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4792711
Max Phase: Preclinical
Molecular Formula: C32H31N3O4
Molecular Weight: 521.62
Molecule Type: Unknown
Associated Items:
ID: ALA4792711
Max Phase: Preclinical
Molecular Formula: C32H31N3O4
Molecular Weight: 521.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(CNc2ccc(CN[C@H](CO)C(=O)O)c(OCc3cccc(C#N)c3)c2)cccc1-c1ccccc1
Standard InChI: InChI=1S/C32H31N3O4/c1-22-26(11-6-12-29(22)25-9-3-2-4-10-25)18-34-28-14-13-27(19-35-30(20-36)32(37)38)31(16-28)39-21-24-8-5-7-23(15-24)17-33/h2-16,30,34-36H,18-21H2,1H3,(H,37,38)/t30-/m1/s1
Standard InChI Key: HWLMUXYCTGZUML-SSEXGKCCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.62 | Molecular Weight (Monoisotopic): 521.2315 | AlogP: 5.26 | #Rotatable Bonds: 12 |
Polar Surface Area: 114.61 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 0.75 | CX Basic pKa: 8.49 | CX LogP: 2.84 | CX LogD: 2.81 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.20 | Np Likeness Score: -0.81 |
1. Guo J,Luo L,Wang Z,Hu N,Wang W,Xie F,Liang E,Yan X,Xiao J,Li S. (2020) Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In Vivo., 63 (22): [PMID:33186040] [10.1021/acs.jmedchem.0c01329] |
Source(1):